Stay updated on Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    A new page revision entry 'Revision: v3.6.6' has been added and the previous entry 'Revision: v3.6.5' has been removed. This signals an updated version of the page used for the study record.
    Difference
    0.1%
    Check dated 2026-08-29T18:43:28.000Z thumbnail image
  4. Check
    21 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.6.4 to v3.6.5. This indicates a software version update.
    Difference
    0.1%
    Check dated 2026-08-08T09:56:51.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    - The page's revision tag was updated from v3.6.3 to v3.6.4, representing a new revision of the page's documentation.
    Difference
    0.1%
    Check dated 2026-07-25T06:42:59.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3. This indicates a newer version of the study page has been published.
    Difference
    0.1%
    Check dated 2026-07-03T22:15:52.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.6.0 to v3.6.2, indicating a newer revision of the page content.
    Difference
    0.1%
    Check dated 2026-06-27T00:00:56.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    The study page now shows No longer looking for participants, indicating recruitment has closed. New or updated help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) along with a standardized Intervention/Treatment label and a new revision note (Revision: v3.6.0).
    Difference
    0.5%
    Check dated 2026-06-12T14:41:45.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.